Location
United Kingdom, Europe
Check Size
$25K - $5M
Investment Stage
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
Medical Devices
About Investor
Shahzad Malik is a General Partner at Advent Life Sciences in London, deploying $25 K–$5 M capital into Series A and B biotech, pharmaceuticals, medical-device and diagnostics companies. He most recently backed NeoDiagnosis, a next-gen point-of-care diagnostic developer. Before Advent, he was a healthcare investment banker at Jefferies, advising life-sciences clients on M&A and capital-markets transactions.
Previous investments
Relief Cardiovascular
12M |2025
Moximed
61M |2024
40M |2022
50M |2017
MiroBio
97M |2022
33M |2019
Similar Investors
MM
Malek Meslemani
United Kingdom, Europe
$5K - $50K
Seed
,Series A
,MW
Michael Whitfield
United Kingdom, Europe
$5K - $50K
Pre Seed
,Seed
,RC
Ronald Cohen
United Kingdom, Europe
$5K - $50K
Pre Seed
,Seed
,JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,RL
Rosemary Leith
United Kingdom, Europe
$5K - $50K
Seed
,Series A
,RS
Russell Smith
United Kingdom, Europe
$5K - $50K
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free